168 related articles for article (PubMed ID: 35813633)
1. N-Butanol Extract of Modified You-Gui-Yin Attenuates Osteoclastogenesis and Ameliorates Osteoporosis by Inhibiting RANKL-Mediated NF-κB Signaling.
Zeng Q; Xu R; Ling H; Zhao S; Wang X; Yuan W; Gu M; Xu T; Wang P; Ruan H; Jin H; Qu H; Ye F; Chen J
Front Endocrinol (Lausanne); 2022; 13():925848. PubMed ID: 35813633
[TBL] [Abstract][Full Text] [Related]
2. Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF-κB Signaling Pathway.
Yuan SG; Hu HL; Wang XJ; Yang JC; Zhou RP; Bai XC; Lai PL
Orthop Surg; 2022 Jun; 14(6):1203-1216. PubMed ID: 35470579
[TBL] [Abstract][Full Text] [Related]
3. A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-
Wong P; Lv Z; Li J; Wei Q; Xu L; Fang B; Luo Y; He M
Oxid Med Cell Longev; 2022; 2022():5982014. PubMed ID: 36388169
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen gas protects against ovariectomy-induced osteoporosis by inhibiting NF-κB activation.
Wu G; Pan L; Sun J; Chen G; Wang S
Menopause; 2019 Jul; 26(7):785-792. PubMed ID: 31083022
[TBL] [Abstract][Full Text] [Related]
5. Rosavin suppresses osteoclastogenesis
Zhang W; Zhang W; Huo L; Chai Y; Liu Z; Ren Z; Yu C
Ann Transl Med; 2021 Mar; 9(5):383. PubMed ID: 33842604
[TBL] [Abstract][Full Text] [Related]
6. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
[TBL] [Abstract][Full Text] [Related]
7. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
[TBL] [Abstract][Full Text] [Related]
8. Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways.
Chen K; Yan Z; Wang Y; Yang Y; Cai M; Huang C; Li B; Yang M; Zhou X; Wei X; Yang C; Chen Z; Zhai X; Li M
Biomed Pharmacother; 2020 Jun; 126():110067. PubMed ID: 32272431
[TBL] [Abstract][Full Text] [Related]
9. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
[TBL] [Abstract][Full Text] [Related]
10. Aloperine improves osteoporosis in ovariectomized mice by inhibiting RANKL-induced NF-κB, ERK and JNK approaches.
Hu R; Chen L; Chen X; Xie Z; Xia C; Chen Y
Int Immunopharmacol; 2021 Aug; 97():107720. PubMed ID: 33945918
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhizin improves bone metabolism in ovariectomized mice via inactivating NF-κB signaling.
Tang Y; Lv XL; Bao YZ; Wang JR
Climacteric; 2021 Jun; 24(3):253-260. PubMed ID: 33084419
[TBL] [Abstract][Full Text] [Related]
12. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
13. Bu-Shen-Tong-Luo decoction prevents bone loss via inhibition of bone resorption and enhancement of angiogenesis in ovariectomy-induced osteoporosis of rats.
Yuan H; Xiao L; Min W; Yuan W; Lu S; Huang G
J Ethnopharmacol; 2018 Jun; 220():228-238. PubMed ID: 29317302
[TBL] [Abstract][Full Text] [Related]
14. HDAC inhibitor quisinostat prevents estrogen deficiency-induced bone loss by suppressing bone resorption and promoting bone formation in mice.
Sun S; Xiu C; Chai L; Chen X; Zhang L; Liu Q; Chen J; Zhou H
Eur J Pharmacol; 2022 Jul; 927():175073. PubMed ID: 35636521
[TBL] [Abstract][Full Text] [Related]
15. Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways.
Yin Z; Zhu W; Wu Q; Zhang Q; Guo S; Liu T; Li S; Chen X; Peng D; Ouyang Z
Eur J Pharmacol; 2019 Sep; 859():172550. PubMed ID: 31323222
[TBL] [Abstract][Full Text] [Related]
16. Dencichine prevents ovariectomy-induced bone loss and inhibits osteoclastogenesis by inhibiting RANKL-associated NF-κB and MAPK signaling pathways.
Cang D; Zou G; Yang C; Shen X; Li F; Wu Y; Ji B
J Pharmacol Sci; 2021 Aug; 146(4):206-215. PubMed ID: 34116734
[TBL] [Abstract][Full Text] [Related]
17. Tectoridin inhibits osteoclastogenesis and bone loss in a murine model of ovariectomy-induced osteoporosis.
Wang J; Tang Y; Lv X; Zhang J; Ma B; Wen X; Bao Y; Wang G
Exp Gerontol; 2020 Oct; 140():111057. PubMed ID: 32798609
[TBL] [Abstract][Full Text] [Related]
18. Senkyunolide H attenuates osteoclastogenesis and postmenopausal osteoporosis by regulating the NF-κB, JNK and ERK signaling pathways.
Yang D; Liu T; Jiang G; Hu X; Zheng T; Li T; Gao Z; Ouyang Z; Zhu B
Biochem Biophys Res Commun; 2020 Dec; 533(3):510-518. PubMed ID: 32977943
[TBL] [Abstract][Full Text] [Related]
19. Melatonin Inhibits Osteoclastogenesis and Bone Loss in Ovariectomized Mice by Regulating PRMT1-Mediated Signaling.
Choi JH; Jang AR; Park MJ; Kim DI; Park JH
Endocrinology; 2021 Jun; 162(6):. PubMed ID: 33713122
[TBL] [Abstract][Full Text] [Related]
20. Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by, suppresses inflammation and downstream NF-κB activated pyroptosis pathways.
Tao H; Li W; Zhang W; Yang C; Zhang C; Liang X; Yin J; Bai J; Ge G; Zhang H; Yang X; Li H; Xu Y; Hao Y; Liu Y; Geng D
Pharmacol Res; 2021 Dec; 174():105967. PubMed ID: 34740817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
